Interestingly, these results also provide a possible explanation for fingolimod-induced cognitive benefits in AD because both TNFα and p75NTR are overexpressed in AD patients, and p75NTR downregulation is able to prevent cognitive and neurite dysfunction in an AD mouse model (Hu et al., 2002; Alvarez et al., 2007; Asle-Rousta et al., 2013a; Knowles et al., 2013; Fukumoto et al., 2014). Here, NGFR is linked to Alzheimer disease.